🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Treatment of higher-risk (intermediate, high and very high) Myelodysplastic...
Status
Completed
Location
AOU Careggi- University of Florence
Start Date
2021-03-24
Trial ID
NCT04806906
Treatments Being Tested
The purpose of this study is to evaluate the safety and efficacy of CC-486 ...
Status
Completed
Location
Winship Cancer Institute of Emory University
Start Date
2015-02-13
Trial ID
NCT02269943
Treatments Being Tested
The purpose of this study is to determine whether a tablet form of azacitid...
Status
Completed
Location
University of Florida
Start Date
2007-09-11
Trial ID
NCT00528983
Treatments Being Tested
The goal of the study is to identify a dose and schedule of CC-486 that can...
Status
Completed
Location
Moffitt Cancer Center
Start Date
2015-04-29
Trial ID
NCT02343536
Treatments Being Tested
The purpose of the study is to determine the maximal tolerated dose and sch...
Status
Completed
Location
Memorial Sloan-Kettering Cancer Center.
Start Date
2013-10-25
Trial ID
NCT01835587
Treatments Being Tested
This study is being done to test the safety and effectiveness of the combin...
Status
Completed
Location
Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
Start Date
2016-02-19
Trial ID
NCT02512172
Treatments Being Tested
To identify the maximum tolerated dose (MTD) of oral azacitidine on differe...
Status
Terminated
Location
National Cancer Center Hospital East
Start Date
2013-07
Trial ID
NCT01908387
Treatments Being Tested
This study is a multicentric, open-label, randomized phase 3 trial. The stu...
Status
Completed
Location
Local Institution - 41822
Start Date
2018-11-06
Trial ID
NCT03703375
Treatments Being Tested
The purpose of the study is to determine the optimal dose of CC-486 (oral a...
Status
Terminated
Location
UCLA
Start Date
2016-12-20
Trial ID
NCT02900560
Treatments Being Tested
This is a phase 2 study of investigational drug, durvalumab given in combin...
Status
Completed
Location
Princess Margaret Cancer Centre
Start Date
2016-09
Trial ID
NCT02811497
Treatments Being Tested